Clinical trial · Observational
The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to first understand how MSKCC Clinical Genetics Service doctors talk to women with breast cancer about any genetic risks they might carry, and if they help women to think about what they might say, in turn, to their relatives, especially their daughters. A second part of the study asks women for their opinions about when and how their daughters should be told about any genetic risks. All of this will help us develop teaching methods to help our doctors improve the way they talk about genetic risk when women with breast cancer have adolescent daughters.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Counseling | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| focus group & questionaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- focus group & questionaire
- description
- The group will discuss its views about how and when to talk about the risk of getting breast cancer. The focus group will be video recorded and the video recorded material will be later transcribed and carefully analyzed. In addition you will be asked to answer questions about yourself, such as education and marital status.
- interventionNames
- Behavioral: focus group & questionaire
Primary outcomes (1)
- measure
- Is a demonstration of the effectiveness of the module in changing the behavior of clinicians after taking part in the communication skills module.
- timeFrame
- conclusion of study
Secondary outcomes (1)
- measure
- To examine the views of women about the provision of genetic risk information to their daughters.
- timeFrame
- conclusion of study
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 12 Years
- Maximum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Women seen in the MSK CGS Service who have a diagnosis of breast cancer or * a family history of breast cancer and * have biological daughter(s) in the age range 12-20 years will be eligible to participate in Phase I \& II. * Women who were consented to Phase I will automatically be eligible for Phase II. Exclusion Criteria: * Women seen in the MSK CGS Service will be ineligible if they have no diagnosis of breast cancer and no family history of breast cancer, * do not have a biological daughter, * or have a biological daughter fewer than 12 or greater than 20 years(unless they were consented to Phase 1). * Women will be ineligible if they are not English speaking, * have intellectual or cognitive impairment, * or active mental illness rendering them incapable of giving informed consent, such as might occur with active psychosis.
References
Publications (0)
Data not yet available